Talk title:

What We Don’t Know About RhD

Learning objectives:

1.    Describe RhD normal structure and variants (weak D, partial D)
2.    Recognize the impact of RhD variants when caring for patients with sickle cell disease
3.    Compare laboratory assays that can detect RhD variants and assess the patient's risk of alloimmunization
4.    Describe the protective role of Rh immune globulin against alloimmunization

Speaker:

Glenn Ramsey, MD
Medical Director, Blood Bank, Northwestern Memorial Hospital
Professor of Pathology, Feinberg School of Medicine, Northwestern University
Program Director, Transfusion Medicine Fellowship, McGaw Medical Center of Northwestern University
Medical Director, Patient Blood Management Program, Northwestern Memorial Hospital
Chicago, IL